TP

TetraLogic Pharmaceuticals

IPO

TetraLogic Pharmaceuticals is a biotech company in United States. It has raised $75.3M across 6 rounds, most recently a $5.0M Extension Round in September 2010.

Employees
11–50
Business Model
B2B
Total Funding
$75.3M
Last Round
$5.0M Extension RoundSep 2010
Rounds
6

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 6 funding rounds for this company. The full record is or through the API.

About

TetraLogic Pharmaceuticals (Nasdaq: TLOG) was a clinical-stage biopharmaceutical company focused on discovering, acquiring and developing novel product candidates to treat cancer and infectious diseases. TetraLogic Pharmaceuticals was a privately held Malvern biopharmaceutical company before its Nasdaq listing. Medivir agreed to buy two clinical-stage cancer candidates and their related development programs from Tetralogic Pharmaceuticals for up to $238 million in an acquisition the buyer said would enhance its oncology pipeline.

Summary

It lists 11–50 employees. It has raised $75.3M in total across 6 rounds, most recently a $5.0M Extension Round in Sep 2010.

Funding History

Data from Indexed.vcUpdated
Extension RoundSeries C ExtensionSep 2010
$5.0M

Sign up to see all 6 events

Funding: Series C through Extension Round. Amounts, valuations, and investors where available.

Similar Companies

BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

TetraLogic Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/tetralogic-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/tetralogic-pharmaceuticals" alt="TetraLogic Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>